{
    "eid": "2-s2.0-85164723364",
    "title": "Clinical Outcomes and Associated Factors for Mortality among Pediatric Patients with Carbapenem-Resistant Acinetobacter baumannii",
    "cover-date": "2023-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acinetobacter baumannii",
        "Bacteremia",
        "Carbapenem resistance",
        "Mortality",
        "Pediatrics",
        "Susceptibility"
    ],
    "authors": [
        "Metpeeya Suebsubanant",
        "Pintip Suchartlikitwong",
        "Surinda Kawichai",
        "Suvaporn Anugulruengkitt",
        "Tanittha Chatsuwan",
        "Thanyawee Puthanakit"
    ],
    "citedby-count": 0,
    "ref-count": 44,
    "ref-list": [
        "Acinetobacter baumannii: emergence of a successful pathogen",
        "The value of single-pathogen antibacterial agents",
        "Carbapenem-resistant Acinetobacter baumannii: Colonization, infection and current treatment options",
        "Acinetobacter baumannii: an emerging opportunistic pathogen",
        "Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED Program in China, 2016 to 2020",
        "Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center",
        "Antimicrobial resistance",
        "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis",
        "Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia",
        "Risk factors for mortality in children with Acinetobacter baumannii bacteremia in South Korea: The role of carbapenem resistance",
        "Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study",
        "Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia",
        "Clinical and microbiological analysis of risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia",
        "Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp",
        "Abrupt increaseinrateofimipenemresistanceinAcinetobacter baumannii complex strains isolated from general hospitals in Korea and correlation with carbapenem administration during 2002-2013",
        "Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009",
        "Infectious Diseases Society of America Guidance on the treatment of AmpC \u03b2-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections",
        "Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment",
        "Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis",
        "New treatment options against carbapenem-resistant Acinetobacter baumannii infections",
        "Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections",
        "Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia",
        "Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study",
        "Pediatric sepsis definitions: past, present, and future",
        "Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children",
        "Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children",
        "Controlling an outbreak of multidrug-resistant Acinetobacter baumannii in a Pediatric Intensive Care Unit: a retrospective analysis",
        "Clinical features, risk factors, and outcome of carbapenem-resistant Acinetobacter baumannii bacteremia in a Thai neonatal intensive care unit",
        "Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis",
        "Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy",
        "In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains",
        "In vitro activity of sulbactam in combination with imipenem, meropenem, panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii",
        "Sulbactam enhances in vitro activity of \u03b2-lactam antibiotics against Acinetobacter baumannii",
        "Enhanced bacterial killing with colistin/ sulbactam combination against carbapenem-resistant Acinetobacter baumannii",
        "Use of tigecycline in pediatric patients with infections predominantly due to extensively drug-resistant Gram-negative bacteria"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": []
}